// App-Quantinova.ai

Tu1656 : Integrin ?1?1 Confers PRO-Proliferative and PRO-Migratory Advantage to Colorectal Cancer Cells and Its Over-Expression Is Regulated by the c-Myc Oncogenic Factor

Researchers

Presenter

  • Julie Carrier

Principal Investigators

  • Jean-Francois Beaulieu

Medical Centers

  • Department of Medicine, Universite de Sherbrooke, SHERBROOKE, QC, Canada

  • Laboratory of Intestinal Physiopathology, Department of Anatomy and Cell Biology, FMSS, Universite de Sherbrooke, Sherbrooke, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Breast cancer

Biomarkers

  • cMYC

  • Extracellular signal-regulated kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved